Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy. - Chaigneau, Loïc; Lapp, Eva; Jai, Taha; Dobi, Erion; Martin, Berenger; Curtit, Elsa; Nerich, Virginie (Cancers, 2025)